Beryl Drugs Ltd.

Financial

	Beryl Drugs	Hind Bio Science	Ganga Pharma.
Operational Metrics
Financials
5 yr Average ROE	2.54 %	-26.49 %	1.2 %
5yr average Equity Multiplier	2.23	3.5	1.4
5yr Average Asset Turnover Ratio	1.08	0.28	0.33
5yr Avg Net Profit Margin	0.66 %	-41.21 %	2.35 %
Price to Book	1.05	9.94	0.0
P/E	44.91	293.86	110.65
5yr Avg Cash Conversion Cycle	-619.24 Days	136.38 Days	183.46 Days
Inventory Days	36.1 Days	8.52 Days	158.14 Days
Days Receivable	98.89 Days	155.27 Days	120.91 Days
Days Payable	969.29 Days	118.59 Days	141.14 Days
5yr Average Interest Coverage Ratio	1.68	-43.62	1.42
5yr Avg ROCE	5.73 %	-14.23 %	4.7 %
5yr Avg Operating Profit Margin	7.19 %	-39.73 %	3.58 %
5 yr average Debt to Equity	0.64	2.36	0.3
5yr CAGR Net Profit	72.78 %	-5.59 %	-23.43 %
5yr Average Return on Assets	1.31 %	-8.5 %	0.85 %
Shareholdings
Promoter Holding	26.38 %	12.19 %	50.91 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.46 %	0.0	-15.8 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0